This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
López-Otero A, Ruiz-Delgado GJ, Ruiz-Argüelles GJ . A simplified method for stem cell autografting in multiple myeloma: a single institution experience. Bone Marrow Transplant 2009; 44: 715–719.
Wannesson L, Panzarella T, Mikhael J, Keating A . Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review. Ann Oncol 2007; 18: 623–632. Review.
Carey PJ, Proctor SJ, Taylor P, Hamilton PJ . Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. The Northern Regional Bone Marrow Transplant Group. Blood 1991; 77: 1593–1598.
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, MarÃn-López A, Delgado-Lamas JL . Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol 1998; 58: 161–164.
Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Ruiz-Argüelles A, Pérez-Romano B, Rivadeneyra L . Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience. Acta Haematol 2003; 110: 179–183.
Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, MarÃn-López A, Larregina-DÃez A, Apreza-Molina MG . Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100–103.
Fenk R, Schneider P, Kropff M, Huenerlituerkoglu AN, Steidl U, Aul C, et al., West German Myeloma Study Group. High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study. Br J Haematol 2005; 130: 588–594.
Akkök CA, Holte MR, Tangen JM, Ostenstad B, Bruserud O . Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells. Transfusion 2009; 49: 354–361.
Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T, EBMT Chronic Leukaemia Working Party Complications Subcommittee. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005; 36: 601–603.
Mhaskar R, Kumar A, Behera M, Kharfan-Dabaja MA, Djulbegovic B . Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review. Biol Blood Marrow Transplant 2009; 15: 893–902.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Schroeder, T., Fenk, R., Saure, C. et al. The Mexican Way: a feasible approach to avoid DMSO toxicity. Bone Marrow Transplant 46, 469–471 (2011). https://doi.org/10.1038/bmt.2010.140
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.140
This article is cited by
-
A Retrospective Analysis of Safety and Efficacy of Wharton’s Jelly Stem Cell Administration in Children with Spina Bifida
Stem Cell Reviews and Reports (2019)